{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:48:58Z","timestamp":1786981738024,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T00:00:00Z","timestamp":1387929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11239-013-1035-4","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T03:24:11Z","timestamp":1387855451000},"page":"11-23","source":"Crossref","is-referenced-by-count":13,"title":["Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies"],"prefix":"10.1007","volume":"38","author":[{"given":"Dominick J.","family":"Angiolillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Datto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Raines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville D.","family":"Yeomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,25]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","volume":"120","author":"L Laine","year":"2001","unstructured":"Laine L (2001) Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120:594\u2013606","journal-title":"Gastroenterology"},{"key":"1035_CR2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","volume":"104","author":"FL Lanza","year":"2009","unstructured":"Lanza FL, Chan FK, Quigley EMM (2009) Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 104:728\u2013738","journal-title":"Am J Gastroenterol"},{"key":"1035_CR3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 284:1247\u20131255","journal-title":"JAMA"},{"key":"1035_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0002-9343(91)90118-H","volume":"91","author":"JF Fries","year":"1991","unstructured":"Fries JF, Williams CA, Bloch DA, Michel BA (1991) Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 91:213\u2013222","journal-title":"Am J Med"},{"key":"1035_CR5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.23911","volume":"59","author":"DH Solomon","year":"2008","unstructured":"Solomon DH, Glynn RJ, Rothman KJ et al (2008) Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Rheum 59:1097\u20131104","journal-title":"Arthritis Rheum"},{"key":"1035_CR6","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S et al (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086","journal-title":"BMJ"},{"key":"1035_CR7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3810\/psm.2011.09.1922","volume":"39","author":"SH Roth","year":"2011","unstructured":"Roth SH, Anderson S (2011) The NSAID dilemma: managing osteoarthritis in high-risk patients. Phys Sportsmed 39:62\u201374","journal-title":"Phys Sportsmed"},{"key":"1035_CR8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clinthera.2010.04.009","volume":"32","author":"JM Scheiman","year":"2010","unstructured":"Scheiman JM, Hindley CE (2010) Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events. Clin Ther 32:667\u2013677","journal-title":"Clin Ther"},{"key":"1035_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2036.2008.03905.x","volume":"29","author":"A Rostom","year":"2009","unstructured":"Rostom A, Moayyedi P, Hunt R (2009) Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther 29:481\u2013496","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1046\/j.1365-2036.2002.01355.x","volume":"16","author":"P Serrano","year":"2002","unstructured":"Serrano P, Lanas A, Arroyo MT, Ferreira IJ (2002) Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 16:1945\u20131953","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2004.03.008","volume":"27","author":"C Kim","year":"2004","unstructured":"Kim C, Beckles GL (2004) Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med 27:1\u20137","journal-title":"Am J Prev Med"},{"key":"1035_CR12","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","volume":"118","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF\/ACG\/AHA 2008 Expert Consensus Document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 118:1894\u20131909","journal-title":"Circulation"},{"key":"1035_CR13","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","volume":"103","author":"FKL Chan","year":"2008","unstructured":"Chan FKL, Abraham NS, Scheiman JM, Laine L (2008) Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the first international working party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Am J Gastroenterol 103:2908\u20132918","journal-title":"Am J Gastroenterol"},{"key":"1035_CR14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.23934","volume":"59","author":"SP Desai","year":"2008","unstructured":"Desai SP, Solomon DH, Abramson SP et al (2008) Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 59:1058\u20131073","journal-title":"Arthritis Rheum"},{"key":"1035_CR15","unstructured":"National Institute for Health and Clinical Excellence. Osteoarthritis: the care and management of osteoarthritis in adults. NICE clinical guideline 59, 2008. http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG59NICEguideline.pdf . Accessed 24 Jan 2013"},{"key":"1035_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartilage 16:137\u2013162","journal-title":"Osteoarthr Cartilage"},{"key":"1035_CR17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","volume":"103","author":"N Yeomans","year":"2008","unstructured":"Yeomans N, Lanas A, Labenz J et al (2008) Efficacy of esomeprazole (20\u00a0mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol 103:2465\u20132473","journal-title":"Am J Gastroenterol"},{"key":"1035_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/egh.11.42","volume":"5","author":"ND Yeomans","year":"2011","unstructured":"Yeomans ND (2011) Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid. Expert Rev Gastroenterol Hepatol 5:447\u2013455","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1035_CR19","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","volume":"346","author":"KC Lai","year":"2002","unstructured":"Lai KC, Lam SK, Chu KM et al (2002) Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346:2033\u20132038","journal-title":"N Engl J Med"},{"key":"1035_CR20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2005.08.003","volume":"129","author":"NS Abraham","year":"2005","unstructured":"Abraham NS, El-Serag HB, Johnson ML et al (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 129:1171\u20131178","journal-title":"Gastroenterology"},{"key":"1035_CR21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2006.08.016","volume":"4","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, Howard KB, Walton SM et al (2006) Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Clin Gastroenterol Hepatol 4:1337\u20131345","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1035_CR22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.2003.01795.x","volume":"18","author":"MCJM Sturkenboom","year":"2003","unstructured":"Sturkenboom MCJM, Burke TA, Tangelder MJD et al (2003) Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 18:1137\u20131147","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 3","key":"1035_CR23","first-page":"iii23","volume":"42","author":"MCJM Sturkenboom","year":"2003","unstructured":"Sturkenboom MCJM, Burke TA, Dieleman JP et al (2003) Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 42(Suppl 3):iii23\u2013iii31","journal-title":"Rheumatology (Oxford)"},{"key":"1035_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2007.03358.x","volume":"26","author":"EM Soest van","year":"2007","unstructured":"van Soest EM, Sturkenboom MCJM, Dieleman JP et al (2007) Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage. Aliment Pharmacol Ther 26:265\u2013275","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2011.580340","volume":"27","author":"MC Hochberg","year":"2011","unstructured":"Hochberg MC, Fort JG, Svensson O et al (2011) Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials. Curr Med Res Opin 27:1243\u20131253","journal-title":"Curr Med Res Opin"},{"key":"1035_CR26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2036.2010.04378.x","volume":"32","author":"JL Goldstein","year":"2010","unstructured":"Goldstein JL, Hochberg MC, Fort JG et al (2010) Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. Aliment Pharmacol Ther 32:401\u2013413","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1185\/03007995.2011.555756","volume":"27","author":"MB Sostek","year":"2011","unstructured":"Sostek MB, Fort JG, Estborn L, Vikman K (2011) Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers. Curr Med Res Opin 27:847\u2013854","journal-title":"Curr Med Res Opin"},{"key":"1035_CR28","unstructured":"European Medicines Compendium UK. Vimovo\u2122, 2012. www.medicines.org.uk\/EMC\/medicine\/23883\/SPC\/VIMOVO+500+mg+20+mg+modified-release-tablets\/ . Accessed 7 June 2012"},{"key":"1035_CR29","unstructured":"Food and Drug Administration (FDA). VIMOVO\u2122 prescribing information, 2010. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022511lbl.pdf . Accessed 17 May 2012"},{"key":"1035_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","volume":"119","author":"G Singh","year":"2006","unstructured":"Singh G, Fort JG, Goldstein JL et al (2006) Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 119:255\u2013266","journal-title":"Am J Med"},{"key":"1035_CR31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","volume":"55","author":"A Lanas","year":"2006","unstructured":"Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT et al (2006) Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55:1731\u20131738","journal-title":"Gut"},{"key":"1035_CR32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2036.2006.03043.x","volume":"24","author":"L Laine","year":"2006","unstructured":"Laine L, Smith R, Min K et al (2006) Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 24:751\u2013767","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR33","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2006.02912.x","volume":"23","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, Lowry SC, Lanza FL et al (2006) The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Aliment Pharmacol Ther 23:1489\u20131498","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2036.2008.03610.x","volume":"27","author":"ND Yeomans","year":"2008","unstructured":"Yeomans ND, Naesdal J (2008) Systematic review: ulcer definition in NSAID ulcer prevention trials. Aliment Pharmacol Ther 27:465\u2013472","journal-title":"Aliment Pharmacol Ther"},{"key":"1035_CR35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.51.3.344","volume":"51","author":"CJ Hawkey","year":"2002","unstructured":"Hawkey CJ, Wilson I, Naesdal J et al (2002) Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut 51:344\u2013350","journal-title":"Gut"},{"key":"1035_CR36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"CJ Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepanski L et al (1998) Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 338:727\u2013734","journal-title":"N Engl J Med"},{"key":"1035_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02090067","volume":"39","author":"JM Scheiman","year":"1994","unstructured":"Scheiman JM, Behler EM, Loeffler KM, Elta GH (1994) Omeprazole ameliorates aspirin-induced gastroduodenal injury. Dig Dis Sci 39:97\u2013103","journal-title":"Dig Dis Sci"},{"key":"1035_CR38","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.clinthera.2004.10.002","volume":"26","author":"JL Goldstein","year":"2004","unstructured":"Goldstein JL, Huang B, Amer F, Christopoulos NG (2004) Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post hoc subanalysis. Clin Ther 26:1637\u20131643","journal-title":"Clin Ther"},{"key":"1035_CR39","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/01.CIR.0000124715.27937.78","volume":"109","author":"ML Capone","year":"2004","unstructured":"Capone ML, Tacconelli S, Sciulli MG et al (2004) Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Circulation 109:1468\u20131471","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-1035-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-013-1035-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-1035-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T05:18:19Z","timestamp":1564982299000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-013-1035-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s11239-013-1035-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,25]]}}}